Keywords: Biotechnology, Diagnostics, Drug Discovery
In the past 40 years, E. coli-based DNA cloning has been one of the major time- and labor-consuming steps in molecular biology. This approach is the first to eliminate E. coli from DNA cloning for protein and RNA expression in human cells. Rather than days spent on E. colibased work, this method simply requires a 30-minute single-tube approach that employs the joining of two or more double-stranded DNA molecules in a single, brief, room temperature reaction, enabling the direct use of the resulting reaction products in human cells for efficient expression of RNAs and/or proteins. In addition to the time saved, a major advantage of this approach is its high yield, which eliminates the need for traditional amplification of the reaction products in bacteria prior to the use in human cells. There is a significant commercial opportunity as nearly every molecular biology lab in the world currently uses laborious E.coli-based DNA cloning.
DNA-cloning for expressing RNA and proteins in human cells.
The Lucky7 approach combines two activities in a single 30-minute, room temperature reaction: the 5’-exonucleolytic activity of T7 DNA Exonuclease and the nick-sealing activity of T7 DNA ligase. In this reaction, precisely positioned phosphonothioate DNA modifications serve as stops for T7 DNA Exonuclease, producing fully defined perfectly matching single-stranded sticky ends for annealing of a DNA insert to nano-backbone. T7 DNA Ligase seals the newly formed insert-backbone nicks simultaneously with the process of sticky end formation and annealing. Following a 10- minute column clean-up, the reaction products are ready for use in human cells. In comparison to conventional E. coli-based DNA cloning methods, the Lucky7 approach requires none of the following procedures: DNA restriction digest, utilization of E. coli competent cells, transformation of DNA into E. coli, plating of transformed bacteria on LB plates followed by their overnight incubation, bacterial colony picking, secondary overnight growth of bacterial cultures in liquid LB media, bacterial culture centrifugation, mini/midi/maxipreps of plasmid from pelleted bacteria, and endotoxin removal from the bacteria derived plasmid DNA.
2024-008
Dr. Andrei Alexandrov, Rui "Jerry" Che, Bhoomi Mirani, Monireh Mohammadpanah
Pushparajah Thavarajah
Business Development Associate
E: pthavar@clemson.edu
P: (864)656-5708
Contact
Stay up-to-date with the latest trends in the innovation and research industry. Sign up for our newsletter to see how CURF is making a difference and impacting the economy where we live.